Related references
Note: Only part of the references are listed.Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
Jennifer A. Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I trial of single-dose temozolomide and continuous administration of O6-benzylguanine in children with brain tumors:: a Pediatric Brain Tumor Consortium report
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors - A report from the children's oncology group
H. Stacy Nicholson et al.
CANCER (2007)
Chemoradiotherapy in malignant glioma: Standard of care and future directions
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas
Dai Ishii et al.
NEUROLOGIA MEDICO-CHIRURGICA (2007)
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
Andrew M. Donson et al.
PEDIATRIC BLOOD & CANCER (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma
Jill A. Maxwell et al.
MOLECULAR CANCER THERAPEUTICS (2006)
ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors
JN Rich et al.
CLINICAL CANCER RESEARCH (2005)
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors
KE Warren et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines
MS Bobola et al.
CLINICAL CANCER RESEARCH (2005)
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children - Results of a multiinstitutional study (SJHG-98)
A Broniscer et al.
CANCER (2005)
Temozolomide as first-line agent in treating high-grade gliomas:: phase II study
S Chibbaro et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates
M Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors
JC Panetta et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study
LS Lashford et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase II trial of carmustine plus O6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
JA Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical relevance of MGMT in the treatment of cancer
SL Gerson
JOURNAL OF CLINICAL ONCOLOGY (2002)
Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: A phase II study
AA Brandes et al.
ONCOLOGY (2002)
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
R Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
